Zydus Cadila seeks nod for needle-free vaccine
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Advertisement
Box: World’s first
The DNA platform-based shot produces spike protein of Covid, causing virus and triggering immune response
Advertisement
It has a needle-free application system
The vaccine storage is at 2-8 degree Celsius
It is 66.6 per cent effective in symptomatic cases, 100% in moderate
Advertisement
Tribune News Service
New Delhi, July 1
Ahmedabad-based Zydus Cadila on Thursday said it had applied to the drug regulator for emergency use authorisation of its three-dose ZyCoV-D Covid-19 vaccine, the world’s first plasmid DNA-based shot.
Shravil Patel, MD, said the vaccine had undergone one of the country’s largest clinical trials. The ZyCoV-D is a three-dose regime as against the currently available two-dose shots.
Zydus Cadila calls it “a no-injection” vaccine, saying it had a needle-free application system. The vaccine is also the first in India to be tested among youngsters in the 12-18 age group, with the company saying it was safe for children.
Advertisement
Advertisement